In the multivariate analysis aimed to prove the independent prognostic value of PTPN2, a higher PTPN2 expression was still an independent prognostic factor in patients with glioma, after adjustment of clinical factors (age, IDH mutation status, and tumor grade). The gene discussed is IDH1; the disease is glioma.